Log in
NASDAQ:ADMP

Adamis Pharmaceuticals Stock Forecast, Price & News

$0.81
-0.06 (-6.91 %)
(As of 10/20/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.78
Now: $0.81
$0.86
50-Day Range
$0.60
MA: $0.79
$1.01
52-Week Range
$0.27
Now: $0.81
$1.51
Volume4.47 million shs
Average Volume3.21 million shs
Market Capitalization$72.73 million
P/E RatioN/A
Dividend YieldN/A
Beta2.07
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States. The company's specialty pharmaceutical product candidates comprise Symjepi (epinephrine) Injection pre-filled syringe (PFS) for use in the emergency treatment of acute allergic reactions, including anaphylaxis. It also offers dry powder inhaler products consisting of albuterol (APC-2000) for the treatment of bronchospasms; fluticasone (APC-4000) for the treatment of asthma; beclomethasone (APC-1000), a metered dose inhaler product for the asthma; Tadalafil (APC-8000) for the treatment of erectile dysfunction; and naloxone injection product candidates (APC-6000) for the treatment of opioid overdose. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, injectables, urological preparations, topical compounds for pain, and men's and women's health products; and certain veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation is headquartered in San Diego, California.
Read More
Adamis Pharmaceuticals logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.2Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.38 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ADMP
CUSIPN/A
Phone858-997-2400
Employees152

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$22.11 million
Book Value$0.58 per share

Profitability

Net Income$-29,310,000.00
Net Margins-170.83%

Miscellaneous

Market Cap$72.73 million
Next Earnings Date11/10/2020 (Estimated)
OptionableOptionable
$0.81
-0.06 (-6.91 %)
(As of 10/20/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ADMP News and Ratings via Email

Sign-up to receive the latest news and ratings for ADMP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Adamis Pharmaceuticals (NASDAQ:ADMP) Frequently Asked Questions

How has Adamis Pharmaceuticals' stock price been impacted by Coronavirus (COVID-19)?

Adamis Pharmaceuticals' stock was trading at $0.4029 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ADMP shares have increased by 100.5% and is now trading at $0.8077.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Adamis Pharmaceuticals?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Adamis Pharmaceuticals in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Adamis Pharmaceuticals
.

When is Adamis Pharmaceuticals' next earnings date?

Adamis Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Adamis Pharmaceuticals
.

How were Adamis Pharmaceuticals' earnings last quarter?

Adamis Pharmaceuticals Corp (NASDAQ:ADMP) announced its earnings results on Monday, August, 17th. The specialty pharmaceutical company reported ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by $0.06. The specialty pharmaceutical company had revenue of $3.93 million for the quarter, compared to the consensus estimate of $5 million. Adamis Pharmaceuticals had a negative return on equity of 87.50% and a negative net margin of 170.83%.
View Adamis Pharmaceuticals' earnings history
.

What price target have analysts set for ADMP?

3 Wall Street analysts have issued 1 year price targets for Adamis Pharmaceuticals' stock. Their forecasts range from $1.00 to $1.50. On average, they expect Adamis Pharmaceuticals' share price to reach $1.25 in the next year. This suggests a possible upside of 54.8% from the stock's current price.
View analysts' price targets for Adamis Pharmaceuticals
.

Are investors shorting Adamis Pharmaceuticals?

Adamis Pharmaceuticals saw a drop in short interest during the month of September. As of September 30th, there was short interest totaling 3,850,000 shares, a drop of 30.5% from the September 15th total of 5,540,000 shares. Based on an average trading volume of 6,950,000 shares, the short-interest ratio is currently 0.6 days.
View Adamis Pharmaceuticals' Short Interest
.

Who are some of Adamis Pharmaceuticals' key competitors?

What other stocks do shareholders of Adamis Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Adamis Pharmaceuticals investors own include Trevena (TRVN), Amarin (AMRN), Sorrento Therapeutics (SRNE), Verastem (VSTM), Dynavax Technologies (DVAX), Novavax (NVAX), SCYNEXIS (SCYX), Synergy Pharmaceuticals (SGYP), Agile Therapeutics (AGRX) and Opko Health (OPK).

Who are Adamis Pharmaceuticals' key executives?

Adamis Pharmaceuticals' management team includes the following people:
  • Mr. Richard C. Williams, Chairman & Consultant (Age 75)
  • Dr. Dennis J. Carlo, Pres, CEO & Director (Age 76)
  • Mr. Robert O. Hopkins, VP of Fin., CFO & Sec. (Age 59)
  • Mr. David J. Marguglio, Sr. VP, Chief Bus. Officer & Director (Age 49)
  • Mr. Robert B. Rothermel, Consultant & Director (Age 75)

What is Adamis Pharmaceuticals' stock symbol?

Adamis Pharmaceuticals trades on the NASDAQ under the ticker symbol "ADMP."

How do I buy shares of Adamis Pharmaceuticals?

Shares of ADMP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Adamis Pharmaceuticals' stock price today?

One share of ADMP stock can currently be purchased for approximately $0.81.

How big of a company is Adamis Pharmaceuticals?

Adamis Pharmaceuticals has a market capitalization of $72.73 million and generates $22.11 million in revenue each year. The specialty pharmaceutical company earns $-29,310,000.00 in net income (profit) each year or ($0.55) on an earnings per share basis. Adamis Pharmaceuticals employs 152 workers across the globe.

What is Adamis Pharmaceuticals' official website?

The official website for Adamis Pharmaceuticals is www.adamispharmaceuticals.com.

How can I contact Adamis Pharmaceuticals?

Adamis Pharmaceuticals' mailing address is 11682 EL CAMINO REAL SUITE 300, SAN DIEGO CA, 92130. The specialty pharmaceutical company can be reached via phone at 858-997-2400 or via email at [email protected]

This page was last updated on 10/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.